| Q55054440 | Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review. |
| Q52646644 | Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis. |
| Q50224610 | Efficacy of vortioxetine in working patients with generalized anxiety disorder |
| Q39169446 | Efficacy, safety, and tolerability of vortioxetine for the treatment of major depressive disorder in patients aged 55 years or older |
| Q88369055 | Initial severity and antidepressant efficacy for anxiety disorders, obsessive-compulsive disorder, and posttraumatic stress disorder: An individual patient data meta-analysis |
| Q34676776 | New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine. |
| Q26797416 | Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice |
| Q59410448 | Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review |
| Q39183229 | Pharmacotherapy in Generalized Anxiety Disorder: Novel Experimental Medicine Models and Emerging Drug Targets. |
| Q42370782 | Short-term efficacy and tolerability of venlafaxine extended release in adults with generalized anxiety disorder without depression: A meta-analysis |
| Q36008269 | The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis |